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Abstract
Background: A scalp block or wound infiltration of local anesthetic is thought to effectively control post-craniotomy
pain. However, it can result in local anesthetic toxicity (LAST), which is difficult to distinguish from brain damage due to
the surgical procedure when emergence from general anesthesia is delayed. Lipid rescue (infusion of a lipid emulsion)
is a widely accepted treatment for LAST.
Case presentation: A 64-year-old man underwent surgical resection of a glioma in the brainstem. While still under
general anesthesia, and before suturing of the wound, he received a 20-mL scalp infusion of ropivacaine 0.75%. His
emergence from anesthesia was delayed, his respiration was suppressed, and premature ventricular contractions
occurred; all of which are symptoms of LAST. Injection of a 20% lipid emulsion rapidly alleviated these symptoms.
Interestingly, the blood concentration of ropivacaine increased after lipid rescue.
Conclusions: The increase in ropivacaine concentration in the blood after lipid rescue suggests that the intravenously
administered lipid emulsion absorbed the ropivacaine from the intoxicated brain and heart tissue. This finding is
consistent with the lipid sink theory as a mechanistic explanation of lipid rescue.
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Background
A scalp block or wound infiltration of local anesthetics
is thought to effectively control post-craniotomy pain
[1]. However, because the scalp has a rich blood flow,
anesthetics locally injected into the scalp are rapidly
absorbed, which increases the risk of local anesthetic
toxicity (LAST) [2, 3]. It is difficult to distinguish be-
tween brain damage and LAST when emergence from
general anesthesia is delayed.
Although numerous studies suggest that lipid rescue
(administration of a lipid emulsion) effectively treats
LAST [4–6], only a few have described LAST under
general anesthesia conditions [7–9]. Reports detailing
changes in the blood concentrations of local anesthetics
after lipid rescue in the clinical setting are also rare [10].
Herein, we present a case in which lipid rescue effect-
ively alleviated LAST in a patient emerging from general
anesthesia after brain tumor surgery and a scalp block
using the local anesthetic ropivacaine. Paradoxically, the
blood concentration of ropivacaine was higher after lipid
rescue compared with that before.
Case presentation
A 62-year-old man (height and weight, 165 cm and
64.2 kg, respectively) had a glioma on the right side of
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his brainstem. He was alert but experienced left hemi-
paresis. He had untreated mild diabetes mellitus
(hemoglobin A1c 6.3%), as well as mild hypertension for
which he was prescribed an angiotensin II receptor an-
tagonist (candesartan cilexetil, 4 mg once daily) and a
Ca2+ channel blocker (amlodipine, 2 mg once daily).
Surgical resection of the glioma under general anesthesia
was planned, with neurological monitoring (motor and
sensory evoked potentials) to determine the resectable
margin of the tumor.
General anesthesia was induced via target-controlled
infusion of propofol (4 μg/mL using a TERUMO infu-
sion pump [TE-371; Terumo Corp. Ltd., Tokyo, Japan])
and continuous infusion of remifentanil (0.5 μg/kg/min),
followed by administration of rocuronium (0.6 mg/kg).
After tracheal intubation, anesthesia was maintained via
target-controlled infusion of propofol (1.8–3.5 μg/mL)
and continuous infusion of remifentanil (0.1–0.3 μg/kg/
min). The bispectral index (BIS) was used to titrate the
propofol dose and was maintained at 40–60 throughout
the anesthesia. Fentanyl was injected intermittently for
transitional analgesia (50–100 μg). The final fentanyl
dose (100 μg) was administered more than 80 min be-
fore the end of the surgery, and the total fentanyl dose
during the surgery was 500 μg. Neurological monitoring
during the surgery was performed in the absence of a
muscle relaxant.
During the surgery, there were no premature ventricular
contractions (PVCs) or other arrhythmias, and the pa-
tient’s circulation and other vital signs were stable. The
patient received an infusion of 1800 mL of a crystalloid so-
lution, 1000 mL of a colloid solution (6% hydroxyethyl
starch in normal saline), and 300 mL of 20% mannitol
(total infusion volume 3100 mL) during the surgery. The
blood loss was 865 mL, but the patient did not receive a
blood transfusion.
After bony closure of the skull, 20 mL of ropivacaine
0.75% (2.34 mg/kg) was infiltrated around the wound
edge. The operating time was 8 h and 42 min. At the
end of the surgery, the propofol/remifentanil infusion
was terminated. However, 30 min later, the patient had
not regained consciousness or spontaneous breathing,
even though the estimated blood concentrations of pro-
pofol and remifentanil were below subanesthetic levels.
At that time, the BIS was approximately 70. The patient
did not become hypothermic during surgery, and his
core body temperature was above 37°C at the end of the
procedure. Blood gas analysis revealed that the blood
pH, oxygenation status, ventilation status, and electro-
lyte status were within normal levels (pH, 7.345; PaCO2,
40.7 torr; PaO2, 129.2 torr; HCO3
–, 21.7 mEq/L; base ex-
cess, -3.7; Na+, 140.6 mEq/L; K+, 3.58 mEq/L; and Ca2+,
1.168 mg/dL) under mandatory ventilation (FIO2, 0.4; VT,
500 mL; respiratory rate, 10/min). However, the PVC
rate gradually increased to 15 beats/min. Taken together,
these observations led us to suspect that LAST had oc-
curred 40 min after ropivacaine infiltration and 30 min
after propofol/remifentanil discontinuation.
We administered a 20% lipid emulsion (Intralipos®;
Ohtsuka Pharmaceuticals, Inc., Tokushima, Japan) as a
bolus of 150 mL, followed by continuous infusion at a
rate of 10 mL/min (total volume 250 mL). After the
bolus was administered, the PVCs disappeared, the
blood pressure increased from 112/62 to 162/79 mmHg,
the PR interval on ECG decreased from 0.16 to 0.12 s,
and spontaneous breathing resumed. After the entire
dose of emulsion was administered, the patient regained
consciousness and responded to call stimuli, and the tra-
cheal tube was removed. He was observed for 30 min in
the operating room and then transferred to the post-
anesthesia care unit in the neurosurgical ward.
To determine the total and free (protein-unbound)
concentrations of ropivacaine, we collected 10 mL blood
samples from the arterial line just before administering
the lipid emulsion, 15 min after extubation (30 min after
administering the lipid emulsion), and 11 h after admin-
istering the lipid emulsion. After sampling, the blood
samples were centrifuged at 5000g for 5 min, and the
supernatant (plasma) was stored at −80 °C until analysis.
The total and free ropivacaine concentrations were de-
termined via liquid chromatography/mass spectrometry
according to previously reported methods [11, 12]. Both
the total and free concentrations, and the free fraction
ratio of ropivacaine, were higher in 30 min after lipid
rescue than before lipid rescue (Fig. 1).
Conclusions
This report describes a case of delayed emergence from
anesthesia in a patient who received a scalp infiltration
of ropivacaine at the end of brain surgery. After infiltra-
tion, the frequency of ventricular arrhythmias increased
and respiration was suppressed. The administration of a
20% lipid emulsion mitigated these symptoms. Owing to
the timing, we thought that LAST had occurred because
delayed emergence from general anesthesia and the
symptoms described above were seen even though the
estimated target concentrations of propofol and opioids
were presumably below subanesthetic levels.
Distinguishing between symptoms of postoperative
LAST and brain damage is difficult because both may
induce disturbance of consciousness, and delayed emer-
gence from general anesthesia after a craniotomy is not
unusual. However, the American Society of Regional
Anesthesia (ASRA) Practice Advisory on Local Anesthetic
Systemic Toxicity has stated that “The practitioner’s
vigilance is of critical importance in recognizing early
signs of LAST (CNS depression [coma, respiratory arrest]
and cardiac excitation [PVCs and tachyarrythmias]),
Hoshino et al. JA Clinical Reports  (2017) 3:9 Page 2 of 5
appreciating their variable presentation, and having a low
threshold for considering LAST in patients that have re-
ceived potentially toxic doses of local anesthetics and
manifest atypical or unexpected signs and symptoms”
[13]. Delayed emergence from general anesthesia, which
was one of the symptoms of LAST in a previous study [9],
may have been the cause of LAST in our case because the
PVC rate increased during the observation period.
Administration of a lipid emulsion resulted in the dis-
appearance of the PVCs and the return of spontaneous
breathing and consciousness.
Lipid rescue was first described by Weinberg et al. [6] in
1998. They showed that an intravenously administered lipid
emulsion prevented cardiac arrest and increased the likeli-
hood of resuscitation after a cardiac arrest induced by
LAST. The ASRA currently recommends lipid rescue
as a first-line therapy for LAST [14]. There are sev-
eral theories as to how lipid rescue reverses LAST.
The well-documented, experimentally tested lipid sink
theory [6, 15] suggests that the lipid emulsion absorbs
the local anesthetic from several tissues (e.g., myocardium,
brain, and vascular smooth muscle), which increases the
metabolic capacity of the liver and, consequently, the
catabolism of the local anesthetic [16].
In our case, the blood ropivacaine concentrations were
higher 30 min after administration of the emulsion when
compared with before. This phenomenon is strange
because “free” local anesthetics are thought to have un-
favorable effects including CNS and cardiac toxicity, and
increases in their amounts after lipid rescue appear to
worsen LAST. However, if the intravenously injected
lipid emulsion absorbs the local anesthetics from the in-
toxicated tissue, their concentrations in the blood would
transiently increase. Such an increase was observed in
our study and is consistent with the lipid sink theory.
Other mechanisms may account for the lipid rescue
phenomenon in patients with LAST. A recent study
showed that infusion of a lipid emulsion reduced the
peak concentrations of local anesthetics by 26 to 30%,
presumably by expediting their clearance [17]. The lipids
may also serve as an energy source for mitochondria,
thereby facilitating the restoration of cellular function in
intoxicated tissues [6, 18]. Alternatively, the lipids may
directly promote the recovery of sodium channel func-
tion [19].
In our patient, the dose of ropivacaine was less than
3 mg/kg, and the plasma concentration of ropivacaine
when LAST was suspected was less than that in a previ-
ous report [2]. In a previous study, the maximum toler-
ated plasma concentrations of ropivacaine in the arterial
blood of healthy volunteers were shown to be in the
microgram per milliliter range [20]. However, our pa-
tient had an adverse cardiac reaction that included an
increase in PVC frequency even though the plasma con-
centration of ropivacaine was below the microgram per
milliliter range. A previous study reported that intraven-
ous administration of a small dose of ropivacaine (36.9
± 8.6) caused cardiac conduction disturbance (elongation
of the PR interval, QRS width, and QT length) and CNS
symptoms in healthy male volunteers [21], and the dose
of ropivacaine in that study was less than half of the
maximal tolerated dose in the study by Knudsen et al.
[20]. Taken together, even a small dose of local
anesthetic, which has been thought not to cause adverse
effects, could potentially lead to CNS and cardiovascular
symptoms. In our case, the PVCs disappeared and
Fig. 1 Total and free concentrations of ropivacaine just before, 30 min, and 11 h after lipid rescue. The concentrations at these time points were
540.6, 617.7, and 159.9 ng/mL (total) and 66, 94.5, and 11.6 ng/nL, respectively (free). The free fraction ratio (free/total) of ropivacaine increased
from 12.2 before lipid rescue to 15.3 after lipid rescue
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hypotension was alleviated after infusion of the lipid
emulsion. These findings suggest that the PVCs were
due to LAST.
The delayed emergence from anesthesia and accom-
panying PVCs in our case were unexpected because we
had not encountered these phenomena in previous crani-
otomies, even when the wound was infiltrated with 20 mL
of 0.75% ropivacaine. However, previous studies on
healthy volunteers suggest that relatively small doses of
local anesthetics can potentially cause CNS dysfunction
[20, 21]. Thereafter, we recommend that neurosurgeons
use ropivacaine or levobupivacaine at concentrations less
than 0.75% (e.g., 0.375 to 0.5%) for wound infiltration.
Conclusions
We strongly recommend that LAST be considered in cases
in which emergence from general anesthesia is delayed
after a scalp block because overlooking this condition can
result in circulatory collapse. On the basis of our own
experience and previous reports, we suggest that lipid res-
cue is an effective and safe treatment for LAST. Lipid
emulsions should be readily available in the operating
room for timely treatment of LAST.
Abbreviations
ASRA: American Society of Regional Anesthesia; BIS: Bispectral index;
LAST: Local anesthetic toxicity; PVC: Premature ventricular contraction
Acknowledgements
The authors thank Editage for the editorial assistance.
Funding
This study was funded solely by the institution and department (Division of
Anesthesiology, Niigata University Graduate School of Medical and Dental
Science and Department of Anesthesiology, Faculty of Medicine, Kanazawa
University, Institute of Medical, Pharmaceutical and Health Science).
Availability of data and materials
Not applicable.
Authors’ contributions
RH and YK anesthetized the patient, collected the data and blood samples,
and wrote the manuscript. YF and TT assisted in the measurement of the
serum ropivacaine concentrations and reviewed the draft of the manuscript.
All the authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Permission was obtained from the patient to report his clinical history prior
to presentation of the case.
Ethics approval and consent to participate
We obtained comprehensive permission from the patient to use his blood
samples for measurement of local anesthetic concentrations. We also
obtained ethical approval from the Institutional Review Board of Niigata
University Medical and Dental Hospital (Approval number: 2035).
Author details
1Division of Anesthesiology, Niigata University Graduate School of Medical
and Dental Sciences, 1-757 Asahimachi-dori, Chuo Ward, Niigata 951-8510,
Japan. 2Department of Anesthesiology, Uonuma Institute of Community
Medicine, Niigata University Medical and Dental Hospital, 4132 Urasa,
Minami-uonuma, Niigata 949-7302, Japan. 3Department of Anesthesiology,
Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Science,
Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8641, Japan.
4Department of Anesthesiology, Ishikawa Prefectural Central Hospital, 2-1
Kuratsuki-higashi, Kanazawa, Ishikawa 920-8201, Japan. 5Department of
Anesthesiology, The Jikei University School of Medicine, 3-25-8
Nishi-shinbashi, Minato Ward, Tokyo 105-8461, Japan.
Received: 26 August 2016 Accepted: 18 January 2017
References
1. Nguyen A, Girard F, Boudreault D, Fugere F, Ruel M, Moumdjian R, et al.
Scalp nerve blocks decrease the severity of pain after craniotomy. Anesth
Analg. 2001;93:1272–6.
2. Costello TG, Cormack JR, Hoy C, Wyss A, Braniff V, Martin K, et al. Plasma
ropivacaine levels following scalp block for awake craniotomy. J Neurosurg
Anesthesiol. 2004;16:147–50.
3. Costello TG, Cormack JR, Mather LE, LaFerlita B, Murphy MA, Harris K. Plasma
levobupivacaine concentrations following scalp block in patients
undergoing awake craniotomy. Br J Anaesth. 2005;94:848–51.
4. Oda Y, Ikeda Y. Effect of lipid emulsion on the central nervous system and
cardiac toxicity of bupivacaine and levobupivacaine in awake rats. J Anesth.
2013;27:500–4.
5. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful
use of a 20% lipid emulsion to resuscitate a patient after a presumed
bupivacaine-related cardiac arrest. Anesthesiology. 2006;105:217–8.
6. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ.
Pretreatment or resuscitation with a lipid infusion shifts the dose-response
to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88:1071–5.
7. Sakai T, Manabe W, Kamitani T, Takeyama E, Nakano S. Ropivacaine-induced
late-onset systemic toxicity after transversus abdominis plane block under
general anesthesia: successful reversal with 20% lipid emulsion. Masui.
2010;59:1502–5. Japanese.
8. Scherrer V, Compere V, Loisel C, Dureuil B. Cardiac arrest from local
anesthetic toxicity after a field block and transversus abdominis plane
block: a consequence of miscommunication between the anesthesiologist and
surgeon. A A Case Rep. 2013;1:75–6.
9. Yukioka H, Hayashi M, Fujimori M. Lidocaine intoxication during general
anesthesia. Anesth Analg. 1990;71:207–8.
10. Litz RJ, Roessel T, Heller AR, Stehr SN. Reversal of central nervous system
and cardiac toxicity after local anesthetic intoxication by lipid emulsion
injection. Anesth Analg. 2008;106:1575–7.
11. Engman M, Neidenstrom P, Norsten-Hoog C, Wiklund SJ, Bondesson U,
Arvidsson T. Determination of ropivacaine and [2H3]ropivacaine in biological
samples by gas chromatography with nitrogen-phosphorus detection or
mass spectrometry. J Chromatogr B Biomed Sci Appl. 1998;709:57–67.
12. Yokogawa K, Shimomura S, Ishizaki J, Shimada T, Fukuwa C, Kawada M, et
al. Involvement of alpha1-acid glycoprotein in inter-individual variation of
disposition kinetics of ropivacaine following epidural infusion in off-pump
coronary artery bypass grafting. J Pharm Pharmacol. 2007;59:67–73.
13. Neal JM, Bernards CM, Butterworth 4th JF, Di Gregorio G, Drasner K,
Hejtmanek MR, et al. ASRA practice advisory on local anesthetic systemic
toxicity. Reg Anesth Pain Med. 2010;35:152–61.
14. Neal JM, Mulroy MF, Weinberg GL, American Society of Regional Anesthesia
and Pain Medicine. American Society of Regional Anesthesia and Pain
Medicine checklist for managing local anesthetic systemic toxicity: 2012
version. Reg Anesth Pain Med. 2012;37:16–8.
15. Weinberg GL. Lipid emulsion infusion: resuscitation for local anesthetic and
other drug overdose. Anesthesiology. 2012;117:180–7.
16. Shi K, Xia Y, Wang Q, Wu Y, Dong X, Chen C, et al. The effect of lipid
emulsion on pharmacokinetics and tissue distribution of bupivacaine in rats.
Anesth Analg. 2013;116:804–9.
17. Dureau P, Charbit B, Nicolas N, Benhamou D, Mazoit JX. Effect of Intralipid®
on the dose of ropivacaine or levobupivacaine tolerated by volunteers: a
clinical and pharmacokinetic study. Anesthesiology. 2016;125:474–83.
18. Partownavid P, Umar S, Li J, Rahman S, Eghbali M. Fatty-acid oxidation
and calcium homeostasis are involved in the rescue of bupivacaine-
induced cardiotoxicity by lipid emulsion in rats. Crit Care Med.
2012;40:2431–7.
Hoshino et al. JA Clinical Reports  (2017) 3:9 Page 4 of 5
19. Wagner M, Zausig YA, Ruf S, Rudakova E, Gruber M, Graf BM, et al. Lipid
rescue reverses the bupivacaine-induced block of the fast Na + current (INa)
in cardiomyocytes of the rat left ventricle. Anesthesiology. 2014;120:724–36.
20. Knudsen K, Beckman Suurkula M, Blomberg S, Sjovall J, Edvardsson N.
Central nervous and cardiovascular effects of i.v. infusions of ropivacaine,
bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78:507–14.
21. Stewart J, Kellett N, Castro D. The central nervous system and cardiovascular
effects of levobupivacaine and ropivacaine in healthy volunteers. Anesth
Analg. 2003;97:412–6.
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Hoshino et al. JA Clinical Reports  (2017) 3:9 Page 5 of 5
